NutriBand (NTRB) Other Non Operating Income (2019 - 2026)
NutriBand (NTRB) posted Other Non Operating Income of $17403.0 for Q2 2026, down 94.84% sequentially from $337528.0 in Q3 2025, and down 42.96% YoY from $30508.0 in Q2 2025.
NutriBand (NTRB) Other Non Operating Income (2019 - 2026) Analysis & Trends
NutriBand has reported Other Non Operating Income for 8 years, with the latest figure at $17403.0 in Q2 2026.
- Quarterly Other Non Operating Income fell 42.96% year-over-year to $17403.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $354931.0 (up 205.16% YoY) and the FY2026 annual result came in at $368036.0, up 200.0% from the prior year.
- Other Non Operating Income fell to $17403.0 in Q2 2026 per NTRB's latest filing, from $337528.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $483183.0 in Q1 2022 and troughed at -$368036.0 in Q3 2024.
- A 5-year average of $45690.2 and a median of -$658.5 in 2022 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 4519.0% in 2024, down 7282.87% in 2024.
- Over 5 years, Other Non Operating Income stood at -$3966.0 in 2022, then plunged by 818.68% to -$36435.0 in 2023, then plunged by 910.12% to -$368036.0 in 2024, then soared by 191.71% to $337528.0 in 2025, then slumped by 94.84% to $17403.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $17403.0, $337528.0, and $30508.0 for Q2 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 17,403.00 |
| Jul 31, 2025 | 337,528.00 |
| Apr 30, 2025 | 30,508.00 |
| Jul 31, 2024 | -368,036.00 |
| Apr 30, 2024 | -8,600.00 |
| Jan 31, 2024 | 194,737.00 |
| Oct 31, 2023 | -36,435.00 |
| Jul 31, 2023 | -4,985.00 |
| Apr 30, 2023 | 2,649.00 |
| Jan 31, 2023 | 4,216.00 |
| Oct 31, 2022 | -3,966.00 |
| Jul 31, 2022 | -4,429.00 |
| Apr 30, 2022 | -4,110.00 |
| Jan 31, 2022 | 483,183.00 |
| Oct 31, 2021 | -196,589.00 |
| Jul 31, 2021 | -37,681.00 |
| Apr 30, 2021 | -993.00 |
| Oct 31, 2020 | -1,618.00 |
| Jul 31, 2020 | -51.00 |
| Apr 30, 2020 | 22,096.00 |